🔎 Trials Near Me

Hem › Crohns sjukdom › Texas › Houston

Kliniska studier för Crohns sjukdom i Houston, TX

17 studier för Crohns sjukdom söker deltagare vid platser i och runt Houston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • Baylor College of Medicine Medical Center ( Site 5020), Houston
  • Michael E. DeBakey VA Medical Center ( Site 5086), Houston
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekryterarFas 2
  • Integrity Advanced Therapeutics /ID# 283871, Houston
  • Novel Research - Bellaire /ID# 280925, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekryterarFas 4
  • Kelsey Research Foundation, Houston
  • MedCare Pharma LLC, Houston
  • Spring Clinical Research, Houston
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekryterarFas 2
  • Houston Methodist Hospital /ID# 265533, Houston
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2/3
  • Victorium Clinical Research, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Novel Research, LLC, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RekryterarFas 1
  • UT MD Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • The University of Texas Health Science Center at Houston, Houston
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekryterarFas 4
  • The University of Texas Health Science Center at Houston, Houston
Ålder 18 till 70 · Alla kön · Uppdaterad 9 sep. 2026 · NCT06045754

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

RekryterarObservationsstudie
  • BAMC, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT04372108

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekryterar
  • Baylor College of Medicine, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT05230173

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

RekryterarObservationsstudie
  • M D Anderson Cancer Center, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 20 maj 2026 · NCT04751396

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekryterarFas 3
  • Texas Children's Hospital - Baylor - PIN, Houston
Ålder 2 och äldre · Alla kön · Uppdaterad 7 maj 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

RekryterarFas 3
  • Texas Children's Hospital, Houston
Ålder 2 till 17 · Alla kön · Uppdaterad 5 maj 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Houston Methodist Hospital, Houston
  • Novel Research, LLC, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekryterarFas 2
  • Mirador Therapeutics Selected Site, Houston
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

RekryterarFas 4
  • Houston Methodist Hospital, Houston
Ålder 18 till 80 · Alla kön · Uppdaterad 15 jan. 2026 · NCT06257706

Crohns sjukdom-studier i andra städer

Andra studier i Houston

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.